Work

PET/CT Imaging of 64CU-Labelled HER2 Liposomal Doxorubicin (64CU-MM-302) Quantifies Variability of Liposomal Drug Delivery to Diverse Tumor Lesions in HER2-Positive Breast Cancer Patients

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu068.1

Authors: B. Hendriks, A. Shields, B.A. Siegel, K. Miller, P. Munster, C. Ma, K. Campbell, V. Moyo, T. Wickham, P. LoRusso

Institutions: Merrimack Pharmaceuticals (United States), The Barbara Ann Karmanos Cancer Institute, Washington University in St. Louis, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Barbara Ann Karmanos Cancer Institute

OpenAlex ID: W1976016507

FWCI: 1.203

Cites:

Cited by: 10

Related to: 10